233 related articles for article (PubMed ID: 30652072)
1. Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis.
Liu JY; Dong XX; Lu JN; Zhang Y; Liu KF; Liu LF; E QZ; Lu XJ; Yin JY; Shen YP
FEBS Open Bio; 2019 Jan; 9(1):35-42. PubMed ID: 30652072
[TBL] [Abstract][Full Text] [Related]
2. Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.
Liu SS; Wan QS; Lv C; Wang JK; Jiang S; Cai D; Liu MS; Wang T; Zhang KH
BMC Cancer; 2024 Apr; 24(1):465. PubMed ID: 38622522
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
4. Association between growth differentiation factor 15 levels and gestational diabetes mellitus: A combined analysis.
Lu YC; Liu SL; Zhang YS; Liang F; Zhu XY; Xiao Y; Wang J; Ding C; Banerjee S; Yin JY; Ma QP
Front Endocrinol (Lausanne); 2023; 14():1084896. PubMed ID: 36742413
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
6. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of growth differentiation factor-15 in trichostatin A-induced apoptosis could play a role in progression of gastric cancer.
Li YL; Cui W; Gao F; Cao ZG; Li XL; Zhou WX
Int J Clin Exp Pathol; 2015; 8(7):8136-42. PubMed ID: 26339382
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.
Soltani R; Amini M; Mazaheri Moghaddam M; Jebelli A; Ahmadiyan S; Bidar N; Baradaran B; MotieGhader H; Asadi M; Mokhtarzadeh A
Mol Biol Rep; 2022 Jul; 49(7):6817-6826. PubMed ID: 34981339
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the expression and genetic alteration of CLDN18 in gastric cancer.
Li J; Zhang Y; Hu D; Gong T; Xu R; Gao J
Aging (Albany NY); 2020 Jul; 12(14):14271-14284. PubMed ID: 32668412
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MMP14 predicts the poor prognosis in gastric cancer: Meta-analysis and database validation.
Wang X; Meng Q; Wang Y; Gao Y
Medicine (Baltimore); 2021 Aug; 100(32):e26545. PubMed ID: 34397871
[TBL] [Abstract][Full Text] [Related]
11. ZNF677 downregulation by promoter hypermethylation as a driver event through gastric tumorigenesis.
Bidar N; Rezaei T; Amini M; Jebelli A; Mokhtarzadeh A; Baradaran B
Exp Mol Pathol; 2021 Aug; 121():104663. PubMed ID: 34171355
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of PURPL and downregulation of NONHSAT062994 as potential biomarkers in gastric cancer.
Moridi H; Karimi J; Tavilani H; Khodadadi I; Emami Razavi AN
Life Sci; 2019 Nov; 237():116904. PubMed ID: 31606380
[TBL] [Abstract][Full Text] [Related]
14. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
16. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990
[TBL] [Abstract][Full Text] [Related]
17. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
He XY; Zhao J; Chen ZQ; Jin R; Liu CY
Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
[TBL] [Abstract][Full Text] [Related]
18. Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma.
Han X; Li X; Zhao H; Zhou D; Sun B; Liu A; Zhang J; Cui Z; Ma X; Yuan L
J Cell Biochem; 2019 Sep; 120(9):15834-15843. PubMed ID: 31081157
[TBL] [Abstract][Full Text] [Related]
19. Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.
Dai J; Li ZX; Zhang Y; Ma JL; Zhou T; You WC; Li WQ; Pan KF
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00004. PubMed ID: 30702489
[TBL] [Abstract][Full Text] [Related]
20. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
Zhu C; Xiao D
Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
